Welcome to CapLaw


CapLaw is a digital newsletter with international reach established and led by the General Editors. We provide up-to-date information on legal and regulatory developments regarding the capital markets, publish concise articles on developments in the Swiss and international financial markets, and announce recent deals and forthcoming events. CapLaw is addressed to all Swiss and international lawyers, in-house counsel, financial institutions and corporates, as well as those who are interested in the Swiss capital markets.

  • Swiss Shakti Foundation launches digital note program  

    The Swiss Shakti Foundation has established its SXE Digital SMART Note Issuance Program. The notes issued under the program qualify as ledger-based securities. Under the program structure, 90% of the proceeds from each tranche of notes will be allocated to investor collateral, while 10% will support the Foundation’s „Project” — a global initiative addressing school participation deficits through a Proof-of-Effort (PoE) blockchain protocol gifted by the Foundation’s founder.


    Read more: Swiss Shakti Foundation launches digital note program  
  • Clariant places two CHF bond tranches 

    Muttenz-based specialty chemicals company Clariant has successfully placed two CHF-denominated bond tranches. Tranche A amounts to CHF 125 million with a three-year maturity, while Tranche B totals CHF 140 million and matures in eight years. The net proceeds from the issuance will be used for general corporate purposes.


    Read more: Clariant places two CHF bond tranches 
  • Thermo Fisher issues CHF 1.425 billion bond

    US-based biotech multinational Thermo Fisher Scientific has successfully issued CHF 1.425 billion in bonds under Swiss law. The transaction, structured across five tranches, represents the largest Swiss franc bond issuance by a US corporate to date. The bonds have been provisionally admitted to trading, with an application for definitive admission and listing on the SIX Swiss Exchange already filed. UBS Investment Bank, BNP Paribas (Suisse) and Deutsche Bank’s London Branch (acting through its Zurich Branch) acted as lead managers in the issuance.


    Read more: Thermo Fisher issues CHF 1.425 billion bond
  • Groupe Bader acquires majority stake in Zwahlen & Mayr

    Groupe Bader SA has acquired an indirect 81.47% of the shares in Zwahlen & Mayr S.A., a Swiss company listed on SIX Swiss Exchange. The transaction remains subject to customary closing conditions, with completion expected by mid-April 2025. Founded in 1881, Zwahlen & Mayr specializes in the production of welded, seamless and precision redrawn tubes in stainless steel and nickel alloy, as well as steel constructions. Groupe Bader SA is active in recycling, material recovery and transportation. The group employs over 200 people, operates four companies across nine sites, and reports an annual turnover of approximately CHF 100 million.


    Read more: Groupe Bader acquires majority stake in Zwahlen & Mayr
  • CHF 1.335 billion share placement in Galderma

    Sunshine SwissCo GmbH, a consortium led by EQT, has completed an accelerated bookbuilding process aimed at professional investors in Switzerland and qualified investors abroad, resulting in the placement of 15 million shares in Galderma. The shares were priced at CHF 89 each, generating total gross proceeds of CHF 1,335 million. The placement does not affect EQT’s representation on Galderma’s board of directors. The selling shareholders have agreed to a 90-day lock-up period, subject to customary exceptions, with regard to their remaining participation in Galderma. The banking syndicate in the transaction consisted of Bank of America, BNP Paribas, Goldman Sachs, Morgan…


    Read more: CHF 1.335 billion share placement in Galderma
  • Swiss Life places EUR 500 million senior bond

    Swiss Life has placed a EUR 500 million senior bond. The bond, carrying a 3.75% coupon and maturing in 2035, was placed with European investors. Swiss Life Holding guarantees the bond, and the proceeds will be used for general corporate purposes, including potential refinancing of existing debt. The joint lead managers were BNP Paribas, J.P. Morgan, Natixis and UBS Europe. UBS also served as principal paying agent on the issuance. Swiss Life, listed on SIX Swiss Exchange, provides comprehensive life insurance, pension and financial solutions for both private and corporate clients.


    Read more: Swiss Life places EUR 500 million senior bond
  • EFG International issues CHF 340 million dual-tranche bonds

    Swiss private banking group EFG International has issued CHF 340 million in senior unsecured dual-tranche bonds by EFG Bank. The bonds are listed on SIX Swiss Exchange. Tranche one amounts to CHF 175 million, has a three-year maturity, and carries a fixed coupon of 1.13% per annum. Tranche two totals CHF 165 million, with a six-year maturity and a fixed coupon of 1.45% per annum. Deutsche Bank AG London Branch (acting through its Zurich Branch) and UBS Investment Bank acted as joint lead managers. This issuance follows EFG Bank’s inaugural CHF 370 million dual-tranche issuance in June 2024.


    Read more: EFG International issues CHF 340 million dual-tranche bonds
  • SIG Group places EUR 625 million bond 

    SIG Group has successfully placed EUR 625 million in bonds. The bonds were issued by SIG Combibloc PurchaseCo S.à.r.l. and are guaranteed by SIG Group AG. Carrying a 3.75% coupon, the bonds mature in 2030. Headquartered in Neuhausen am Rheinfall, SIG Group provides global solutions for aseptic carton packaging systems. BNP Paribas and BofA Securities acted as joint global coordinators. Crédit Agricole CIB, Coöperatieve Rabobank U.A., UBS Investment Bank and UniCredit served as active bookrunners.


    Read more: SIG Group places EUR 625 million bond 
  • Galderma debuts on euro and CHF bond markets

    Galderma has completed its inaugural EUR 500 million bond issuance as well as CHF 435 million dual-tranche bond placement. Galderma made its Eurobond market debut with a EUR 500 million issuance maturing in 2030 and carrying a 3.5% coupon. The bonds were issued by Galderma Finance Europe B.V. and guaranteed by Galderma Group. BNP Paribas, Mizuho, J.P. Morgan and Santander Corporate & Investment Banking acted as active joint bookrunners, while Commerzbank, ING and RBC Capital Markets participated as passive joint bookrunners. In parallel, Galderma placed CHF bonds in two tranches. The first tranche amounts to CHF 190 million, with a…


    Read more: Galderma debuts on euro and CHF bond markets
  • Sandoz repays existing bonds and issues new bonds

    Sandoz, a global leader in generics and biosimilars, has announced that it has fully repaid USD 750 million equivalent USD and EUR term loans that were put in place in September 2023, just before its spin-off from Novartis. The repayment was funded through proceeds from successful bond transactions: – On 13 March 2025, Sandoz issued a three-year CHF 165 million and an eight-year CHF 253 million bond, with annual coupons of 2.125% and 1.75%, respectively. – On 17 March 2025, Sandoz issued a single-tranche EUR 500 million bond with a 10-year tenor and an annual coupon of 4%. In addition, a new…


    Read more: Sandoz repays existing bonds and issues new bonds